PROLONGATION OF FIBRINOLYTIC-ACTIVITY OF TISSUE PLASMINOGEN-ACTIVATOR BY NITROVASODILATORS

被引：46

作者：

KORBUT, R

LIDBURY, PS

VANE, JR

机构：

来源：

LANCET | 1990年 / 335卷 / 8690期

关键词：

D O I：

10.1016/0140-6736(90)90462-E

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：669 / 669

页数：1

共 4 条

[1] TISSUE-TYPE PLASMINOGEN-ACTIVATOR - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC USE AS A THROMBOLYTIC AGENT [J].

COLLEN, D ;

LIJNEN, HR ;

TODD, PA ;

GOA, KL .

DRUGS, 1989, 38 (03) :346-388

[2] A RANDOMIZED, BLINDED, PLACEBO-CONTROLLED TRIAL OF RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH UNSTABLE ANGINA-PECTORIS [J].

GOLD, HK ;

JOHNS, JA ;

LEINBACH, RC ;

YASUDA, T ;

GROSSBARD, E ;

ZUSMAN, R ;

COLLEN, D .

CIRCULATION, 1987, 75 (06) :1192-1199

[3] COMPARISON OF 2 DOSE REGIMENS OF INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR FOR ACUTE MYOCARDIAL-INFARCTION [J].

TOPOL, EJ ;

GEORGE, BS ;

KEREIAKES, DJ ;

CANDELA, RJ ;

ABBOTTSMITH, CW ;

STUMP, DC ;

BOSWICK, JM ;

STACK, RS ;

CALIFF, RM .

AMERICAN JOURNAL OF CARDIOLOGY, 1988, 61 (10) :723-728

[4] INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR AND SIZE OF INFARCT, LEFT-VENTRICULAR FUNCTION, AND SURVIVAL IN ACUTE MYOCARDIAL-INFARCTION [J].

VANDEWERF, F ;

ARNOLD, AER .

BMJ-BRITISH MEDICAL JOURNAL, 1988, 297 (6660) :1374-1379

← 1 →